June 10 2008

Burnaby Company Gets Money for Drug Trials

Immune system booster seen as way to help beat superbugs resistant to antibiotics

By Gillian Shaw, Published: Tuesday, June 10, 2007

(Pictured: CEO and President John North )

Imagine your own body mustering its defences to successfully fight off a superbug that is resistant to antibiotics.

That's the dream of Burnaby's Inimex Pharmaceuticals, one that has already been proven in animal studies and now has the backing of a major Hong Kong venture capital firm and two pharmaceutical giants that have joined with local venture capital firms to pump $22 million US into the company to see it into human clinical trials... read more